Kui Cheng
机构：National Center for Drug Screening, Southern Medical University · ORCID：0000-0002-4136-2070
发表论文 106 篇 · 总被引 4421 次 · h-index 34
代表论文
- Enzyme-responsive design combined with photodynamic therapy for cancer treatment (2024 · Drug Discovery Today · 被引 21)
- Design, synthesis and anti-tumor evaluation of novel pyrimidine and quinazoline analogues (2024 · European Journal of Medicinal Chemistry · 被引 18)
- A Novel Adamantane-Dioxetane-Based Chemiluminescent Probe for Highly Selective and Sensitive Bioimaging of Hydrogen Peroxide In Vitro and In Vivo (2025 · Analytical Chemistry · 被引 17)
- Staphylococcus aureus vesicles impair cutaneous wound healing through p38 MAPK-MerTK cleavage-mediated inhibition of macrophage efferocytosis (2025 · Cell Communication and Signaling · 被引 15)
- Heterocyclic-Modified Imidazoquinoline Derivatives: Selective TLR7 Agonist Regulates Tumor Microenvironment against Melanoma (2024 · Journal of Medicinal Chemistry · 被引 15)
- Oxymatrine, a novel TLR2 agonist, promotes megakaryopoiesis and thrombopoiesis through the STING/NF-κB pathway (2024 · Journal of Pharmaceutical Analysis · 被引 8)